FR 183998

Drug Profile

FR 183998

Alternative Names: FR183998

Latest Information Update: 17 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Fujisawa
  • Class Anti-ischaemics; Antiarrhythmics; Cardiotonics; Guanidines; Small molecules; Thiophenes
  • Mechanism of Action Sodium hydrogen antiporter inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arrhythmias; Heart failure; Ischaemic heart disorders

Most Recent Events

  • 23 Jun 1998 Commercial data has been reviewed by Fujisawa
  • 03 Oct 1997 Preclinical development for Arrhythmias in Japan (IV)
  • 03 Oct 1997 Preclinical development for Heart failure in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top